LONDON (Reuters) -European and U.S. healthcare stocks surged on Wednesday, propelled by a deal between Pfizer and President Donald Trump to lower prescription drug prices in the Medicaid programme in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback